Trevi Therapeutics Inc (TRVI)

EBITDA Growth

-44.76%

Quarterly · Period ending:

TRVI logo

TRVI EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-44.76%
TRVI Quarterly EBITDA YoY % (-170.96% → -44.76%)
High-resolution chart · PNG

TRVI ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Trevi Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-44.7574%
-27.7681%
26.9278%
11.0079%
0.3003%
5.1499%
-46.3163%
-72.501%
-76.3165%
-76.5833%
-48.2811%
3.7506%
9.8671%
12.2917%
36.1853%
-14.92%
18.2863%
13.0957%
10.6696%
4.026%
-28.4245%
4.6388%
-40.6154%
1.7801%
0.2565%
-76.3898%
-8.541%
-29.674%
-69.2642%
-21.5642%
-170.959%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.